Form 8-K - Current report:
SEC Accession No. 0001213900-16-011502
Filing Date
2016-03-10
Accepted
2016-03-10 17:04:12
Documents
1
Period of Report
2016-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k031016_dandritbio.htm 8-K 10776
  Complete submission text file 0001213900-16-011502.txt   12084
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54478 | Film No.: 161498483
SIC: 2834 Pharmaceutical Preparations